Standardising the 'little data' is just common sense. We need it to achieve meaningful health information interoperability beyond simple messages and documents.
Despite some wins, the transition to EHRs has generally been much slower than we anticipated, much harder than we imagined, and it is not hard to argue that interoperability of granular health data remains frustratingly elusive.
I attended the inaugural openEHR meetings in China last week - this is how I introduced openEHR…
Recording adverse reactions, allergies and intolerances to medications and other substances is universally regarded as a high priority for clinical safety. This is the ‘Adverse reaction risk’ archetype’s story - an international, cross SDO collaboration that achieved consensus. It demonstrates the potential value that comes if we choose to work together, rather than create more silos.